Welcome to the Cancer Group at the Primary Care Unit
The Cancer Group is headed by Dr Fiona Walter.
We are a team of multi-disciplinary researchers who focus our research on cancer screening, detection and early diagnosis, mainly in the community and primary care setting.
We are interested in developing strategies to prevent or detect symptomatic cancer earlier using new biomarkers, technological devices, smartphones and clinical decision support. We also conduct research on patient safety, and using risk stratified approaches and genetic advances to detect people at higher risk of cancer.
Our current work focuses on understanding patient pathways and interventions to improve diagnosis of the skin cancer melanoma, oesophageal, gastric, pancreatic, urological, brain, ovarian and colorectal cancer.
Our flagship international research and education programme, the CanTest Collaborative, funded by Cancer Research UK’s first Catalyst award, launched in 2017. This involves research collaborations across 4 UK institutions and with international partners in Australia, Europe and the US. We also work closely with other groups across the Cancer Research UK Cambridge Centre and the Eastern region, and have a parallel programme of research on cancer detection, early diagnosis and follow-up care with the University of Melbourne, Australia.
Cancer Group News
A new study, recently published in Cancers, found that over one-quarter of bladder and kidney cancer patients who met NICE…
A new systematic review guided by the CanTest Framework found that while there is a large number of biomarkers being…